Approximately 10% to 50% of patients with solid tumors and more than 80% of those with hematologic malignancies will develop fever during courses of cytotoxic chemotherapy.  However, an infectious etiology can be established in a minority of patients, and clinically defined infections occur in 20% to 30% of<unk>  episodes.
Febrile neutropenia epidemiology and demographics
Acute myeloid leukemia epidemiology and demographics
Chronic neutrophilic leukemia epidemiology and demographics
Chronic myelogenous leukemia epidemiology and demographics
Chronic lymphocytic leukemia epidemiology and demographics
Myelodysplastic syndrome epidemiology and demographics
Mast cell leukemia epidemiology and demographics
Hairy cell leukemia epidemiology and demographics